Caffeine

Specifications

58-08-2CAS Number

200-362-1EC Number

1,3,7-trimethylpurine-2,6-dioneIUPAC Name

C8H10N4O2Chemical Formula

194.19 g/molMolecular Weight

caffeine; 58-08-2; Guaranine; 1,3,7-Trimethylxanthine; Methyltheobromine; Theine; Thein; Cafeina; Caffein; Cafipel; Koffein; Mateina; Alert-pep; Coffeine; Anhydrous caffeine; Refresh'n; Caffedrine; Vivarin; Stim; No-Doz; Cafamil; Cafecon; Caffine; Dexitac; Nodaca; 7-Methyltheophylline; Eldiatric C; Durvitan; Hycomine; Organex; Nix Nap; Methyltheobromide; Coffeinum; Coffein; 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione; Tirend; 1,3,7-Trimethylpurine-2,6-dione; 1,3,7-Trimethyl-2,6-dioxopurine; Tri-Aqua; Kofein; Caffeine, anhydrous; 1-methyltheobromine; 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-; CAFFEINE ANHYDROUS; Methylxanthine theophylline; teina; Caffeina; 1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione; NCI-C02733; 1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione; FEMA No. 2224; cafeine; Caffeinum; DTXSID0020232; 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione; NSC-5036; Caffeine melting point standard; 3G6A5W338E; DTXCID40232; TREZIX COMPONENT CAFFEINE; CHEBI:27732; NSC5036; NoDoz Caplets and Chewable Tablets; 5-26-13-00558 (Beilstein Handbook Reference); Quick Pep; 3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion; QuickPep; NODOZ; Zanthine; Awake; NoSnooze; Allertness Aid; Diurex Ultimate; trimethylxanthine; Uplift Chewable; Alertness Aid; Diurex Ultra; Yeast-vite; Caffeine,; Conrx Alert; Pro-plus; Sprayable Energy; Stay Awake; Alert Aid; Hair Care; Nano Ppc; Caffeine 200mg; Diurex Water Pills; Topcare Stay Awake; Alert Alertness Aid; NoDoz Alertness Aid; Sohmed Alertness Aid; 357 Super Magnum; Caffeine 1508; Awake Maximum Strength; RefChem:6623; Diurex Water Pills XPL; Caffeine 200 mg Tablets; Jet Alert Double Strength; Jet Alert Regular Strength; Caffeine Tablets, 200 mg; Stay Awake Maximum Strength; Caffeine tablet, film-coated; CHEBI:27134; Topcare Stay Awake Maximum Strength; GROWTH Hair Serum Serum Capillaire; NoDoz Alertness Aid Maximum Strength; Valumeds Maximum Strength Stay Awake; FEELSHION 6% Caffeine 1% Retinol Eye Cream; 200-362-1; 619-173-4; BIOTIN; CITRUS AURANTIUM BERGAMIA (BERGAMOT) FRUIT OIL; CITRUS TANGERINA (TANGERINE) FRUIT; CURCUMA LONGA (TURMERIC) ROOT; LEMON; LYSYLTHREONYLTHREONYLLYSYLSERINE; NICOTIANA BENTHAMIANA WHOLE; TOBACCO LEAF; TRIFOLIUM PRATENSE LEAF; Phensal; Caffeine, synthetic; Quick-Pep; Synalgos; Theophylline, 7-methyl; DHCplus; Miudol; Theobromine, 1-methyl-; Propoxyphene Compound 65; Kofein [Czech]; Coffein [German]; Koffein [German]; Caffeine (natural); Xanthine, 1,3,7-trimethyl; Caffeina [Italian]; Theophylline Me; Theobromine Me; SK-65 Compound; Anacin; Anacin Maximum Strength; P-A-C Analgesic Tablets; HSDB 36; BRN 0017705; NSC 5036; A.S.A. and Codeine Compound; AI3-20154; MFCD00005758; CHEMBL113; CFF; caffenium; SK 65 Compound; Caffeine [BAN:JAN]; 1,3,7-trimethyl-1,3,7-trihydropurine-2,6-dione; CAS-58-08-2; Caffeine (USP); SMR000326667; CCRIS 1314; SR-01000075187; Anhydrous caffeine (TN); EINECS 200-362-1; Monomethyl derivative of Theophylline; Caffeine [USP:BAN:JAN]; Anhydrous caffeine (JP15); metilteobromina; Kafeina; trimetilksantina; UNII-3G6A5W338E; Guaranine;; Coffeine;; Caffeine RS; Theine;; Caffeine CRS; Methyltheobromine;; 1gfz; Caffeine, BioXtra; Caffeine for system suitability CRS; TNP00310; Monohydrate Caffeine; Respia (TN); 1-methyl-Theobromine; Caffeine M.P. RS; 7-methyl Theophylline; Cafergot (Salt/Mix); 1,7-Trimethylxanthine; Spectrum_001301; 1l5q; 1l7x; 2a3b; 3g6m; 3,7-dihydro-1,3,7-trimethyl-1H-purine; CAFFEINE [FHFI]; CAFFEINE [HSDB]; CAFFEINE [IARC]; CAFFEINE [FCC]; Xanthine,3,7-trimethyl; CAFFEINE [II]; CAFFEINE [MI]; 1 3 7-trimetilksantina; CAFFEINE [VANDF]; CAFFEINUM [HPUS]; Spectrum2_001261; Spectrum3_000321; Spectrum4_001782; Spectrum5_000423; Lopac-C-0750; 1 3 7-Trimethylxanthine; CAFFEINE [MART.]; bmse000206; CAFFEINE [USP-RS]; CAFFEINE [WHO-DD]; CAFFEINE [WHO-IP]; MolMap_000054; Probes1_000150; Probes2_000128; C 0750; EC 200-362-1; SCHEMBL5671; Anhydrous caffeine (JP18); NCIOpen2_008255; BIDD:PXR0172; Lopac0_000228; BSPBio_001921; GTPL407; KBioGR_002325; KBioSS_001781; MLS001055341; MLS001056714; MLS001066409; orb422048; BIDD:ER0554; BIDD:GT0632; Caffeine, 1mg/ml in methanol; DivK1c_000730; SPECTRUM1500155; CU-01000012617-3; SPBio_001222; CAFFEINE [ORANGE BOOK]; ESGIC COMPONENT CAFFEINE; TRIAD COMPONENT CAFFEINE; 829 - Tea quality parameters; MEGxp0_001350; SCHEMBL1341011; SCHEMBL6362289; CAFFEINE [EP MONOGRAPH]; DIMENHYDRINATE IMPURITY C; FEMCET COMPONENT CAFFEINE; 1,3,7-trimethyl-2,6-dioxo-1,2,3,6-tetrahydropurine; ANHYDROUS CAFFEINE [JAN]; CAFFEINE [USP MONOGRAPH]; component of Dilone (Salt/Mix); 1,7-Trimethyl-2,6-dioxopurine; ACon1_000085; ANOQUAN COMPONENT CAFFEINE; BDBM10849; HMS502E12; KBio1_000730; KBio2_001781; KBio2_004349; KBio2_006917; KBio3_001141; Caffeine 1.0 mg/ml in Methanol; COFFEINUM [WHO-IP LATIN]; CAFERGOT COMPONENT CAFFEINE; Caffeine, powder, ReagentPlus(R); component of Percodan (Salt/Mix); EXCEDRIN COMPONENT CAFFEINE; FIORICET COMPONENT CAFFEINE; FIORINAL COMPONENT CAFFEINE; MIGERGOT COMPONENT CAFFEINE; NINDS_000730; NORGESIC COMPONENT CAFFEINE; WIGRAINE COMPONENT CAFFEINE; Bio1_000473; Bio1_000962; Bio1_001451; DHC PLUS COMPONENT CAFFEINE; HMS1920I09; HMS2091O11; HMS2232M13; HMS3260N17; HMS3372J18; HMS3435F10; HMS3715D13; HMS5091J20; Pharmakon1600-01500155; INVAGESIC COMPONENT CAFFEINE; LANORINAL COMPONENT CAFFEINE; Caffeine 10 microg/mL in Methanol; CAFFEINE ANHYDROUS [WHO-IP]; CIA28298; CS-M0795; DDA07266; XCA23885; Tox21_201685; Tox21_300010; Tox21_500228; caffeine (1,3,7-trimethylxanthine); Caffeine 100 microg/mL in Methanol; CCG-38825; EBC-03517; HB2846; NSC755917; ORPHENGESIC COMPONENT CAFFEINE; PDSP1_001016; PDSP1_001235; PDSP2_001000; PDSP2_001219; SBB006474; STK177283; Propoxyphene Compound 65 (Salt/Mix); SYNALGOS-DC COMPONENT CAFFEINE; AKOS000121334; 5-26-13-00558 (Beilstein); Bayer Select Headache Pain (Salt/Mix); Caffeine, anhydrous, 99%, FCC, FG; DB00201; FT05891; LP00228; NSC-755917; SDCCGMLS-0064595.P001; SDCCGMLS-0064595.P002; SDCCGSBI-0050216.P005; IDI1_000730; MEDIGESIC PLUS COMPONENT CAFFEINE; SYNALGOS-DC-A COMPONENT CAFFEINE; 3,3,7-trimethyl-1H-purine-2,6-dione; DARVON COMPOUND COMPONENT CAFFEINE; INVAGESIC FORTE COMPONENT CAFFEINE; NCGC00015208-01; NCGC00015208-02; NCGC00015208-03; NCGC00015208-04; NCGC00015208-05; NCGC00015208-06; NCGC00015208-07; NCGC00015208-08; NCGC00015208-10; NCGC00015208-11; NCGC00015208-12; NCGC00015208-13; NCGC00015208-14; NCGC00015208-15; NCGC00015208-16; NCGC00015208-17; NCGC00015208-18; NCGC00015208-20; NCGC00015208-27; NCGC00015208-29; NCGC00090699-01; NCGC00090699-02; NCGC00090699-03; NCGC00090699-04; NCGC00090699-05; NCGC00090699-06; NCGC00090699-07; NCGC00090699-08; NCGC00090699-09; NCGC00168808-01; NCGC00168808-02; NCGC00254057-01; NCGC00259234-01; NCGC00260913-01; AC-12774; AS-15340; Caffeine, SAJ special grade, >=98.5%; component of P-A-C Compound (Salt/Mix); ST057528; component of A.S.A. Compound (Salt/Mix); ORPHENGESIC FORTE COMPONENT CAFFEINE; SBI-0050216.P004; DB-023002; WLN: T56 BN DN FNVNVJ B1 F1 H1; C2042; EU-0100228; NS00000273; THEOPHYLLINE IMPURITY A [EP IMPURITY]; 526 - Nutritional Analysis of Energy Drinks; EN300-21663; BIM-0050216.0001; C07481; D00528; DIMENHYDRINATE IMPURITY C [EP IMPURITY]; PENTOXIFYLLINE IMPURITY F [EP IMPURITY]; Q60235; 1,3,7-trimethyl-3,7-dihydropurine-2,6-dione; 1H-Purine-2, 3,7-dihydro-1,3,7-trimethyl-; AB00051930-09; AB00051930_10; Caffeine, purum, anhydrous, >=99.0% (HPLC); 3,7-dihydro-1,3,7-trimethyl-1H-purine (9CI); Caffeine, anhydrous, tested according to Ph.Eur.; L000155; Caffeine, Sigma Reference Standard, vial of 250 mg; SR-01000075187-1; SR-01000075187-4; SR-01000075187-7; SR-01000075187-8; BRD-K02404261-001-02-7; BRD-K02404261-001-03-5; BRD-K02404261-001-07-6; BRD-K02404261-001-16-7; Caffeine, certified reference material, TraceCERT(R); Caffeine, meets USP testing specifications, anhydrous; Melting point standard 235-237C, analytical standard; 1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione #; Caffeine, British Pharmacopoeia (BP) Reference Standard; Caffeine, European Pharmacopoeia (EP) Reference Standard; F3371-0262; THEOPHYLLINE MONOHYDRATE IMPURITY A [EP IMPURITY]; Z104507896; 07E4FB58-FD79-4175-8E3D-05BF96954522; 3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion (coffein); Caffeine, United States Pharmacopeia (USP) Reference Standard; Reagecon Melting Point Caffeine +235 to +237 degrees C Standard; Caffeine, Pharmaceutical Secondary Standard; Certified Reference Material; Caffeine for system suitability, European Pharmacopoeia (EP) Reference Standard; Caffeine melting point standard, United States Pharmacopeia (USP) Reference Standard; InChI=1/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H; 114303-55-8; Caffeine Melting Point Standard, Pharmaceutical Secondary Standard; Certified Reference Material; Mettler-Toledo Calibration substance ME 18872, Caffeine, analytical standard, for the calibration of the thermosystem 900, traceable to primary standards (LGC); Caffeine Hydrate; Cafein monohydrat; Cafeina anhidra; Caféine anhydreSynonyms